RecruitingNCT07043413

Thrombus Analysis of Ischemic Stroke


Sponsor

Seoul National University Hospital

Enrollment

500 participants

Start Date

Jan 25, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Patients with acute ischemic stroke who have undergone endovascular thrombectomy will be eligible to be included, and thrombus will be collected after obtaining informed consent. Enrolled patients will receive a comprehensive diagnostic evaluation and the best medical treatment according to recent stroke management guidelines. The mechanism of the stroke will be classified into atherosclerotic, cardiac embolism, others and unknown causes based on diagnostic workup. Patients will be monitored in an outpatient clinic for vascular events including stroke recurrence, death, and bleeding events, which will continue for up to two years after the initial stroke event. Thrombus information related to RNA expression patterns and histological characteristics will be analyzed to classify the stroke mechanism and predict future vascular events after the initial stroke.


Eligibility

Inclusion Criteria1

  • patients with acute ischemic stroke who had undergone endovascular thrombectomy

Exclusion Criteria1

  • \-

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTthrombus analysis

Detailed expression pattern of RNA and histological characteristics will be investigated.


Locations(1)

Seoul National University Hospital

Seoul, Jong-ro Gu, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07043413


Related Trials